Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancers|February 24, 2024
Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical ExperienceKhaled Dibs, Emile Gogineni, Sachin M Jhawar, et al.
Anticancer Research|December 11, 2013
Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapyWaleed F Mourad, Kenneth S Hu, Daniel Shasha, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
Cancers|March 28, 2024
Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct CarcinomaEmile Gogineni, Blake E Sells, Khaled Dibs, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer PatientsJustin D Anderson, Todd A DeWees, Daniel J Ma, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2017
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's diseaseStephen Salloway, Jose E Gamez, Upinder Singh, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical TrialDavid M Routman, Kathryn M Van Abel, Katharine A Price, et al.
JAMA Neurology|January 27, 2015
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque densityCraig Curtis, Jose E Gamez, Upinder Singh, et al.
Pageof 5